CA2560972A1 - Proteomic analysis of biological fluids - Google Patents

Proteomic analysis of biological fluids Download PDF

Info

Publication number
CA2560972A1
CA2560972A1 CA002560972A CA2560972A CA2560972A1 CA 2560972 A1 CA2560972 A1 CA 2560972A1 CA 002560972 A CA002560972 A CA 002560972A CA 2560972 A CA2560972 A CA 2560972A CA 2560972 A1 CA2560972 A1 CA 2560972A1
Authority
CA
Canada
Prior art keywords
protein
proteomic profile
proteins
precursor
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002560972A
Other languages
English (en)
French (fr)
Inventor
Ron Rosenfeld
Sri Nagalla
Mike Gravett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hologic Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2560972A1 publication Critical patent/CA2560972A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002560972A 2003-03-25 2004-03-23 Proteomic analysis of biological fluids Abandoned CA2560972A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/400,005 US7191068B2 (en) 2003-03-25 2003-03-25 Proteomic analysis of biological fluids
US10/400,005 2003-03-25
PCT/US2004/008954 WO2004088324A2 (en) 2003-03-25 2004-03-23 Proteomic analysis of biological fluids

Publications (1)

Publication Number Publication Date
CA2560972A1 true CA2560972A1 (en) 2004-10-14

Family

ID=33096805

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002560972A Abandoned CA2560972A1 (en) 2003-03-25 2004-03-23 Proteomic analysis of biological fluids

Country Status (12)

Country Link
US (3) US7191068B2 (enExample)
EP (2) EP2088433A1 (enExample)
JP (2) JP2006524331A (enExample)
CN (1) CN1795387A (enExample)
AT (1) ATE423322T1 (enExample)
AU (2) AU2004225527B2 (enExample)
CA (1) CA2560972A1 (enExample)
DE (1) DE602004019511D1 (enExample)
DK (1) DK1618388T3 (enExample)
ES (1) ES2322593T3 (enExample)
MX (1) MXPA05010325A (enExample)
WO (1) WO2004088324A2 (enExample)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127962A1 (en) * 2002-11-14 2006-06-15 Ciphergen Biosystems, Inc. Biomarkers for intro-amniotic inflammation
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
GB0313828D0 (en) 2003-06-16 2003-07-23 Owen Smith Brian D O Salivary urate for diagnosis of pre-eclampsia
US8165661B2 (en) * 2003-08-21 2012-04-24 Mcgill University Method and apparatus for analyzing amniotic fluid
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
WO2005093413A2 (en) * 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
JP2007536939A (ja) * 2004-05-14 2007-12-20 アモークス インコーポレーティッド 免疫細胞バイオセンサーおよびその使用方法
US9488655B2 (en) * 2004-07-14 2016-11-08 The Regents Of The University Of California Biomarkers for detection of early- and late-stage endometrial cancer
US7670792B2 (en) * 2004-07-14 2010-03-02 The Regents Of The University Of California Biomarkers for early detection of ovarian cancer
US9487575B2 (en) 2004-07-14 2016-11-08 The Regents Of The University Of California Compositions and methods for treatment of gynecologic cancers
EP1789805B1 (en) 2004-07-14 2010-09-15 The Regents of The University of California Biomarker for early detection of ovarian cancer
JP2008513031A (ja) * 2004-09-20 2008-05-01 プロテオジェニックス， インコーポレイテッド 胎児異数性の診断
KR20070092737A (ko) * 2004-12-15 2007-09-13 베스 이스라엘 데코니스 메디칼 센터 임신 합병증의 진단 및 치료에 유용한 핵산 및 폴리펩티드
CA2595377A1 (en) 2005-01-28 2006-08-03 Children's Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers
JP5219516B2 (ja) * 2005-03-18 2013-06-26 ザ チャイニーズ ユニバーシティー オブ ホンコン 染色体異数性の検出方法
US7767395B2 (en) 2005-04-15 2010-08-03 Becton, Dickinson And Company Diagnosis of sepsis
US20070087387A1 (en) 2005-04-21 2007-04-19 Prasad Devarajan Method for the Early Detection of Renal Disease Using Proteomics
EP2189541A3 (en) * 2005-09-09 2010-09-08 University of Iowa Research Foundation Methods and reagents for treatment and diagnosis of age-related macular degeneration
US7312079B1 (en) 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
US20070190580A1 (en) * 2005-10-31 2007-08-16 Beckman Coulter, Inc. Immunoassay of Fragments of Insulin-Like Growth Factor Binding Proteins
US7981399B2 (en) * 2006-01-09 2011-07-19 Mcgill University Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
WO2007089734A2 (en) * 2006-01-27 2007-08-09 Eastern Virginia Medical School Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential
US7790463B2 (en) 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
WO2007109293A2 (en) * 2006-03-21 2007-09-27 Yale University Early diagnosis of congenital abnormalities in the offspring of diabetic mothers
WO2008019491A1 (en) * 2006-08-16 2008-02-21 National Research Council Of Canada Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein
AU2007312960A1 (en) * 2006-10-20 2008-04-24 Newcastle Innovation Limited Assay for the detection of biomarkers associated with pregnancy related conditions
JP5194212B2 (ja) * 2006-12-26 2013-05-08 ブリガム・ヤング・ユニバーシティ 血清プロテオミクスシステムと関連する方法
WO2008112424A1 (en) * 2007-03-08 2008-09-18 Mayo Foundation For Medical Education And Research Assessing heart failure
WO2008134881A1 (en) * 2007-05-05 2008-11-13 The University Of Western Ontario Methods for the detection of preeclampsia
GB0711327D0 (en) * 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
FR2919060B1 (fr) 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
FR2919065B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
ES2565512T3 (es) 2007-07-19 2016-04-05 bioMérieux Procedimiento de ensayo de la proteína de unión a ácidos grasos del hígado, de ACE y de CA19-9 para el diagnóstico in vitro del cáncer colorrectal
EP2179288A4 (en) * 2007-07-20 2010-07-21 Univ Utah Res Found IDENTIFYING AND QUANTIFYING BIOMARKERS TO EVALUATE THE RISK OF A BREAKFAST
WO2009046447A1 (en) * 2007-10-06 2009-04-09 Katalin Polgar Fetal open lesion detection system
WO2009076425A2 (en) * 2007-12-13 2009-06-18 3M Innovative Properties Company Methods of analyzing wound samples
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
US20100017143A1 (en) * 2008-01-30 2010-01-21 Proteogenix, Inc. Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
US8481273B2 (en) * 2008-06-20 2013-07-09 University Of Delaware Perlecan fragments as biomarkers of bone stromal lysis
WO2009158423A1 (en) * 2008-06-25 2009-12-30 University Of Utah Research Foundation Identifying and quantifying biomarkers associated with preeclampsia
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
US8476008B2 (en) 2008-07-23 2013-07-02 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
WO2011053832A1 (en) * 2009-10-29 2011-05-05 The Trustees Of Columbia University In The City Of New York Use of urinary ngal to diagnose sepsis in very low birth weight infants
JP5781530B2 (ja) * 2009-11-25 2015-09-24 ホロジック, インコーポレイテッドHologic, Inc. 羊膜内感染の検出
CA2792622A1 (en) * 2010-03-11 2011-09-15 University Of Louisville Research Foundation, Inc. Methods of predicting and decreasing the risk of pregnancy loss
ES2667066T3 (es) 2010-05-24 2018-05-09 The Trustees Of Columbia University In The City Of New York Proteínas NGAL mutantes y usos de las mismas
US20130072437A1 (en) * 2010-05-28 2013-03-21 Mind-Nrg Sa Neuregulin isoforms,neuregulin polypeptides and uses thereof
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
CN103415769B (zh) * 2010-12-06 2017-04-12 迈卡蒂斯股份有限公司 用于妊娠性高血压疾病的生物标志物和参数
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
WO2013016510A1 (en) * 2011-07-27 2013-01-31 Baylor College Of Medicine Process for preparing biological samples
CA2846865A1 (en) 2011-08-29 2013-03-07 The Regents Of The University Of California Use of hdl-related molecules to treat and prevent proinflammatory conditions
KR101142434B1 (ko) * 2011-09-08 2012-05-08 (주)오비메드 조기양막파수 산모에서 비침습적인 양수 내 염증 및 감염의 예측 또는 진단 방법
CN102426243B (zh) * 2011-11-17 2014-03-19 成都创宜生物科技有限公司 以补体因子d为检测指标的子痫前期检测试剂盒的制备方法
CN104884080A (zh) 2012-08-03 2015-09-02 Lfb美国股份有限公司 抗凝血酶在体外膜式氧合中的用途
EP2912458B1 (en) 2012-10-24 2018-07-18 NYU Winthrop Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
WO2014081980A2 (en) 2012-11-21 2014-05-30 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof
CA2890306C (en) * 2012-12-20 2018-06-19 F. Hoffmann-La Roche Ag Characterization of thermostable dna polymerase
GB201305317D0 (en) * 2013-03-22 2013-05-08 Iles Raymond K Prenatal screening for fetal abnormalities and disorders of pregnancy
US10126305B2 (en) 2013-06-25 2018-11-13 University of Pittsburg—Of the Commonwealth System of Higher Education Proteomic biomarkers of sepsis in elderly patients
FR3036188B1 (fr) * 2015-05-12 2019-06-07 Biomerieux Prediction du risque de developper, pour des patients admis en service de reanimation, une infection disseminee
JP6840391B2 (ja) * 2015-06-19 2021-03-10 セラ プログノスティックス， インコーポレイテッド 早産を予測するためのバイオマーカーの対
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
CN105372414B (zh) * 2015-10-09 2017-12-22 成都大熊猫繁育研究基地 大熊猫乳汁中关键因子的分析方法
US11693006B2 (en) 2016-12-20 2023-07-04 Sangui Bio Pty. Ltd Blood profiling with protease inhibitors
EP3668996A4 (en) 2017-08-18 2021-04-21 Sera Prognostics, Inc. PREGNANCY CLOCK PROTEIN TO PREDICT THE EXPECTED DATE AND TIME OF BIRTH
KR20200109293A (ko) 2017-09-13 2020-09-22 프로제너티, 인크. 자간전증 바이오마커 및 관련된 시스템 및 방법
US20190224277A1 (en) * 2018-01-22 2019-07-25 CyPhi LLC Bio-mimetic formulation
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
CN113092773A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-胰蛋白酶抑制剂重链H4及其多肽片段在过敏性疾病中的应用
CN113092771A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-1B-糖蛋白及其多肽片段在过敏性疾病中的应用
CN111951969A (zh) * 2020-08-05 2020-11-17 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用
WO2025243332A1 (en) * 2024-05-24 2025-11-27 Intignus Biotech Private Limited Lfa device for detecting biomarkers for intrapartum and neonatal complications and method thereof
CN120233090B (zh) * 2025-03-28 2025-09-09 中日友好医院(中日友好临床医学研究所) 一组尿蛋白标志物及其在制备非小细胞肺癌预后预测产品中的应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871937A (en) * 1985-04-30 1999-02-16 The Scripps Research Institute Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
US5516702A (en) * 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
WO1996037777A1 (en) * 1995-05-23 1996-11-28 Nelson Randall W Mass spectrometric immunoassay
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
EP1056886A1 (en) * 1998-02-25 2000-12-06 National University of Ireland, Cork Hla linked pre-eclampsia and miscarriage susceptibility gene
US6324479B1 (en) * 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
EP1143246A4 (en) * 1998-12-28 2004-11-24 Advance Kk IDENTIFICATION SYSTEM OF MICROORGANISMS
WO2000052471A1 (en) * 1999-03-01 2000-09-08 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for chorioamnionitis
JP2002541457A (ja) * 1999-04-07 2002-12-03 ユニリーバー・ナームローゼ・ベンノートシヤープ リポ多糖の免疫測定法と試験装置
WO2001008700A1 (en) * 1999-07-28 2001-02-08 Genetics Institute, Inc. Preventing immune-mediated abortion by inhibiting costimulation
US6653151B2 (en) * 1999-07-30 2003-11-25 Large Scale Proteomics Corporation Dry deposition of materials for microarrays using matrix displacement
EP1234060A2 (en) * 1999-11-30 2002-08-28 OXO Chemie AG Evaluating and predicting clinical outcomes by gene expression analysis
EP1481249A1 (en) * 2002-03-07 2004-12-01 Cambridge University Technical Services Limited Scd fingerprints
CN1395103A (zh) * 2002-07-31 2003-02-05 中华人民共和国北京出入境检验检疫局 疯牛病病原检测压电生物芯片及其制备方法
US20060127962A1 (en) * 2002-11-14 2006-06-15 Ciphergen Biosystems, Inc. Biomarkers for intro-amniotic inflammation
US20060240495A1 (en) * 2003-02-05 2006-10-26 Ciphergen Biosystems, Inc. Non-invasive assessment of intra-amniotic environment
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
JP4568282B2 (ja) * 2003-09-23 2010-10-27 ザ ジェネラル ホスピタル コーポレイション 妊娠性疾患のスクリーニング
US20060063162A1 (en) * 2004-09-23 2006-03-23 Deng David X Biological marker for inflammation
EP1805500A4 (en) * 2004-09-28 2008-05-07 Singulex Inc SYSTEM AND METHOD FOR THE SPECTROSCOPIC ANALYSIS OF INDIVIDUAL PARTICLES
GB0426982D0 (en) * 2004-12-09 2005-01-12 Secr Defence Early detection of sepsis
US7767395B2 (en) * 2005-04-15 2010-08-03 Becton, Dickinson And Company Diagnosis of sepsis
DE602006019262D1 (de) * 2005-08-11 2011-02-10 Siemens Healthcare Diagnostics QUANTITATIVE ASSAYS FÜR PDGFR-beta- IN KÖRPERFLÜSSIGKEITEN
JP2009510478A (ja) * 2005-10-03 2009-03-12 バイオサイト インコーポレイテッド 全身性炎症反応症候群の診断および／または予後診断のための方法および組成物
WO2007047041A2 (en) * 2005-10-14 2007-04-26 Hyperion Biotechnology, Inc. Methods and compositions for biomarkers associated with change in physical performance
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
US20080031874A1 (en) * 2006-02-06 2008-02-07 Sanders Martin E Treatment of endotoxemia using endotoxin neutralizing agents
WO2007139359A1 (en) * 2006-05-31 2007-12-06 Hanwha Chemical Corporation Vcam-1 specific monoclonal antibody
US20080199426A1 (en) * 2007-01-11 2008-08-21 Sukhatme Vikas P Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders

Also Published As

Publication number Publication date
JP2006524331A (ja) 2006-10-26
ATE423322T1 (de) 2009-03-15
EP2088433A1 (en) 2009-08-12
AU2004225527A1 (en) 2004-10-14
ES2322593T3 (es) 2009-06-23
EP1618388A2 (en) 2006-01-25
US20090055099A1 (en) 2009-02-26
DE602004019511D1 (de) 2009-04-02
WO2004088324A3 (en) 2005-06-02
US7191068B2 (en) 2007-03-13
DK1618388T3 (da) 2009-05-18
WO2004088324A2 (en) 2004-10-14
JP5011410B2 (ja) 2012-08-29
AU2010200352A1 (en) 2010-02-18
MXPA05010325A (es) 2006-03-17
US20080299594A1 (en) 2008-12-04
US20040197930A1 (en) 2004-10-07
JP2010122238A (ja) 2010-06-03
EP1618388B1 (en) 2009-02-18
AU2004225527B2 (en) 2009-10-29
CN1795387A (zh) 2006-06-28

Similar Documents

Publication Publication Date Title
AU2004225527B2 (en) Proteomic analysis of biological fluids
EP2092344B1 (en) Proteomic analysis of cervical-vaginal fluids for detecting intra-uterine infection or determining pre-term delivery risk in a pregnant female
AU2020201701B2 (en) Biomarkers and methods for predicting preterm birth
JP2006524331A5 (enExample)
US20100017143A1 (en) Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
HK1133922A (en) Proteomic analysis of biological fluids
HK1129926B (en) Proteomic analysis of cervical-vaginal fluids for detecting intra-uterine infection or determining pre-term delivery risk in a pregnant female
Machtejevienė Peptide Pattern of Amniotic Fluid and its Correlation with Protein Composition of Fetal Membranes

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140325